Featured Research

from universities, journals, and other organizations

Skin And Hair Spring From The Same Stem Cells, Researchers Find

Date:
August 18, 2000
Source:
University Of Pennsylvania Medical Center
Summary:
In a study that has implications for understanding the way skin wounds heal and some skin cancers develop, researchers at the University of Pennsylvania Medical Center and New York University School of Medicine have found compelling evidence that the hair follicle and the epidermis may originate from the same cache of cells.

Finding advances understanding of skin wounds and skin cancer

In a study that has implications for understanding the way skin wounds heal and some skin cancers develop, researchers at the University of Pennsylvania Medical Center and New York University School of Medicine have found compelling evidence that the hair follicle and the epidermis may originate from the same cache of cells.

The researchers have traced the earliest daughters of the stem cells (primitive cells not yet committed to a specific developmental pattern) to the section of the upper follicle adjacent to the region where the stem cells reside.

The finding shows clearly for the first time how cells from the hair follicle can directly influence the epidermis.

"Our results suggest that in normal newborns, and in healing wounds throughout life, it is the daughter cells in the upper follicle that migrate upward to form and maintain the new epidermis. The daughter cells of the stem cells also migrate downward to form the hairshaft," said Robert M. Lavker, PhD., professor of dermatology at the University of Pennsylvania School of Medicine.

Lavker has been investigating stem cell systems for nearly 20 years in collaboration with Tung-Tien Sun, PhD, of the NYU School of Medicine. Their current work identifies the upper follicle as the site of young transient amplyfying (TA) cells -- which are the early offspring of stem cells -- and follows the TA cells’migration into the epidermis and into the bulb, or root, of the hair where the TA cells differentiate into components of the hair shaft.

The current study, which will be published in the August 18 issue of Cell, builds on the 1990 research of Lavker and his coworkers, in which they located stem cells at the bulge of the follicle (the point where the outer root sheath attaches to the arrector pili muscle).

The new study furnishes evidence that these researchers were correct at the time when they also postulated that the bulge stem cells are bipotent – capable of generating TA cells that develop along two distinct paths.

Lavker and Sun had proposed that the stem cells were bipotent in order to explain a phenomenon that scientists had been aware of for years, but had never been able to understand: Healthy skin seems capable of self-regeneration. But when a severe burn destroys the skin, epidermal cells are found to emerge from any remaining hair follicles to re-establish the outer skin in circles of re-growth. The precise origin of those new epidermal cells had never been established.

Lavker and Sun’s theory that bulge stem cells were the source of both epidermal cells and hair cells became the basis of their current research. Using young and adult mice, Lavker, Sun and their colleagues devised a double-labeling technique in which they could follow the division of the stem cells, and then observe the trafficking patterns of the early-offspring TA cells.

Results from the study "strongly suggest that the bulge stem cell is bipotent, and that the daughter (TA) cells migrate up to the epidermis and down to the root," Lavker said.

Added Sun: "There’s been a termendous controversy as to where the epidermal stem cells are. We are proposing that there is just one entity -- an ultimate epidermal stem cell -- located in the bulge area of the hair follicle, that is capable of forming skin or hair."

A major "take home message" of the research, Lavker said, is the pivotal importance of the upper follicle in the healing process of the skin: "It places the upper follicle directly in the center, for wound repair."

The work also paves the way for designing effective skin cancer treatment, by explaining why skin tumors that are produced for the purpose of research frequently originate in the upper follicle.

"In addition to wanting to target stem cells in the bulge for skin cancer (stem cells are the prime source of abnormal growth and mutation), now you also have to consider targeting the upper follicle where the TA cells retain most characteristics of the stem cells," Lavker said.

Participating with Lavker and Sun in the research were Michael Lehrer, MD., and Pamela Jensen, PhD., of Penn, and Gina Taylor, MD., of Presbyterian Hospital. The work was funded by the National Institutes of Health.


Story Source:

The above story is based on materials provided by University Of Pennsylvania Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Pennsylvania Medical Center. "Skin And Hair Spring From The Same Stem Cells, Researchers Find." ScienceDaily. ScienceDaily, 18 August 2000. <www.sciencedaily.com/releases/2000/08/000817080356.htm>.
University Of Pennsylvania Medical Center. (2000, August 18). Skin And Hair Spring From The Same Stem Cells, Researchers Find. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2000/08/000817080356.htm
University Of Pennsylvania Medical Center. "Skin And Hair Spring From The Same Stem Cells, Researchers Find." ScienceDaily. www.sciencedaily.com/releases/2000/08/000817080356.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins